Skip to main content

Table 3 Treatment in present study (n = 46)

From: Concurrent paclitaxel-based chemo-radiotherapy for post-surgical microscopic residual tumor at the bronchial margin (R1 resection) in non-small-cell lung cancer

Time-interval between resection and start of treatment

 

Median/range (weeks)

5/4-6

Radiotherapy

 

PTV volume a (cm 3 , median/range)

182.6/162.2-278.4

Irradiation dose for PTV2 b (Gy, median/range)

60/50-70

Number of fractions (median/range)

30/25-35

Total lung V 20 (%,median/range)

21/17-24

Mean lung dose (Gy,median/range)

11.7/10.3-12.8

Chemotherapy

 

Chemotherapy regimens c

 

  Paclitaxel and Cisplatin

31 (67.4%)

  Paclitaxel and Carboplatin

11 (23.9%)

  Paclitaxel and Oxaliplatin

4 (8.7%)

Number of chemotherapy cycles (median/range)

3 (1–4)

Number of concurrent cycles (median/range)

2 (1–3)

  1. a: Planning target volume; b: generated according to the GTV; c: all chemotherapy regimens were delivered per three weeks.